Review Article
Novel Molecular Targets Participating in Myocardial Ischemia-Reperfusion Injury and Cardioprotection
Table 2
Specific function of inflammation in MIRI and cardioprotection.
| Model | Effector | Target | Activity in MIRI | Reference |
| Mouse | PI3K | Erk, Akt, GSK3β | Mediates the protective effect by phosphorylation during the IPC trigger phase | [63] | BAY 60-6583 | A2BR | Modulates proinflammatory kinases via the PI3K/Akt pathway in cardiac M2 macrophage | [61] | TLR5 | Unknown | Deficiency of TLR5 aggravates inflammation | [64] | OPHN1 | RhoA, Rac1, Cdc42 | Deficiency of OPHN1 increases inflammatory cell migration and cardiomyocyte apoptosis | [66] | S-Nitrosation | MIF | Stimulates an overall enhanced protective effect | [67] | Chemerin15 | Unknown | Decreases TNFα and IL-6 levels and increases IL-10 levels | [70] | A20 | Unknown | Reduces cardiomyocyte necrosis and apoptosis | [72] | IKKɑ | Unknown | Causes negative control of macrophage polarization towards M1 phenotype | [57] | TIPE2 | NOD2 | Reduces the levels of proinflammatory mediators and cardiac inflammatory cell infiltration | [79] |
|
|